Vertex Pharmaceuticals Inc (VRTX) stock saw a decline, ending the day at $439.62 which represents a decrease of $-0.11 or -0.03% from the prior close of $439.73. The stock opened at $438.73 and ...

Vertex (VERX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

The Bank of Tanzania (BoT) is taking decisive steps to restore investor interest in medium-term bonds, aiming to align with ...

Vertex Pharmaceuticals Inc (VRTX) stock saw a modest uptick, ending the day at $422 which represents a slight increase of $5.04 or 1.21% from the prior close of $416.96. The stock opened at $422.73 ...

Vertex also has multiple other catalysts on the way in 2025 ... In phase 3 testing, the drug achieved around 50% reduction in ...

The Colorado Springs City Council voted late Tuesday night to accept the annexation request for a large housing development ...

A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...

Despite this dive, the VERTEX price remains N/A% negative since the beginning of the year. The RSI offers additional insight into the market’s momentum by measuring the size of AI VERTEX by Virtuals ...

If you’re on the fence about investing in SolarWinds Corporation, Vertex or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your ...

allowing Alyftrek to be dosed less frequently — once daily instead of twice — and enabling Vertex to pay lower royalties on drug sales. Testing showed the drug was statistically “non-inferior” to ...